US Broker Ratings

Grifols, S.A. (GRFS) Investor Outlook: A Potential 35.81% Upside in the Healthcare Sector

Grifols, S.A. (NASDAQ: GRFS), a key player in the healthcare sector, stands out with its robust product lineup and international reach. As a Spanish company specializing in plasma-derived medicines, Grifols..

Avantor, Inc. (AVTR) Stock Analysis: Navigating a Challenging Landscape with a Strategic Vision

Avantor, Inc. (AVTR), operating in the dynamic healthcare sector, stands as a formidable player in the medical instruments and supplies industry. With a market capitalization of $9.78 billion, the company..

Corcept Therapeutics (CORT) Stock Analysis: Revenue Growth, Target Price, and Investor Insights

Investors eyeing the healthcare sector, particularly in biotechnology, might find Corcept Therapeutics Incorporated (NASDAQ: CORT) an intriguing prospect. With a market capitalization of $13.22 billion, Corcept is a formidable player..

Stevanato Group S.p.A. (STVN) Stock Analysis: A Strong Buy with a 9.86% Upside Potential

Stevanato Group S.p.A. (NYSE: STVN), a leading Italian company in the healthcare sector, continues to capture investor attention with its robust market position and promising growth prospects in the medical..

Regencell Bioscience Holdings L (RGC): Navigating the Volatility in Healthcare Bioscience

Regencell Bioscience Holdings Limited (NASDAQ: RGC) stands at an intriguing crossroads, offering both volatility and opportunity in the ever-evolving healthcare sector. As a Hong Kong-based Traditional Chinese Medicine (TCM) bioscience..

Bio-Techne Corp (TECH) Stock Analysis: Insights into the Biotechnology Leader’s Modest Growth and Solid Market Position

Bio-Techne Corp (NASDAQ: TECH), a key player in the biotechnology industry, offers a compelling investment narrative for those seeking exposure to the healthcare sector. With a market capitalization of $11.27..

Charles River Laboratories (CRL) Stock Analysis: Navigating a Complex Landscape with Strategic Partnerships

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a pivotal player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Wilmington, Massachusetts, the company has..

Medpace Holdings, Inc. (MEDP): Investor Outlook on Growth and Market Position

Medpace Holdings, Inc. (NASDAQ: MEDP) stands out as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $17.33 billion, the..

Biogen Inc. (BIIB) Stock Analysis: Evaluating a Potential 8.67% Upside in the Healthcare Sector

Biogen Inc. (NASDAQ: BIIB), a leading player in the healthcare sector, particularly within the drug manufacturing industry, offers a compelling investment opportunity with a market capitalization of $32.03 billion. As..

Quest Diagnostics (DGX) Stock Analysis: Navigating a Healthy Growth Path in the Diagnostics Sector

Quest Diagnostics Incorporated (NYSE: DGX), a prominent player in the Healthcare sector, operates at the forefront of the Diagnostics & Research industry. Headquartered in Secaucus, New Jersey, Quest Diagnostics provides..

Bruker Corporation (BRKR) Stock Analysis: Navigating Market Waves with a 5.20% Revenue Growth in the Healthcare Sector

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, specifically within the medical devices industry, presents an intriguing opportunity for investors focused on scientific and diagnostic solutions. Founded..

Centene Corporation (CNC): Investor Outlook Amid 10.22% Potential Upside

For investors eyeing opportunities in the healthcare sector, Centene Corporation (NYSE: CNC) presents a compelling case with a potential upside of 10.22%. As a leading player in the healthcare plans..

Solventum Corporation (SOLV) Stock Analysis: Navigating a 4.86% Potential Upside Amidst Healthcare Innovations

Solventum Corporation (NYSE: SOLV), a prominent player in the healthcare sector, is capturing investor attention with its robust portfolio of medical solutions and a notable potential upside of 4.86%. With..

Repligen Corporation (RGEN) Stock Analysis: Navigating Growth with a Robust Buy Consensus

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector specializing in medical instruments and supplies, has captured the attention of investors with its impressive market cap of $10.22..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Navigating Potential 6.58% Upside in the Biotech Sector

Revolution Medicines, Inc. (NASDAQ: RVMD), a pivotal player in the biotechnology sector, is making waves with its innovative approach to treating RAS-addicted cancers. As a clinical-stage precision oncology company, Revolution..

Baxter International Inc. (BAX) Stock Analysis: Navigating Challenges with Potential 9.06% Upside

Baxter International Inc. (NYSE: BAX) remains a noteworthy player in the healthcare sector, primarily within the Medical Instruments & Supplies industry. With a market cap of $13.62 billion, Baxter’s extensive..

AptarGroup, Inc. (ATR) Stock Analysis: Exploring a Potential 26% Upside with Strong Buy Ratings

AptarGroup, Inc. (NYSE: ATR) presents an intriguing opportunity for investors eyeing the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $8.57 billion, this..

Encompass Health Corporation (EHC) Stock Analysis: Unlocking a Potential 23% Upside

Encompass Health Corporation (NYSE: EHC), a leading entity in the Medical Care Facilities sector, presents a compelling opportunity for investors seeking growth in the healthcare industry. With a market capitalization..

Exelixis, Inc. (EXEL) Investor Outlook: Analyzing Its 44.39% Return on Equity Amidst Strong Buy Ratings

For investors looking to navigate the healthcare sector, Exelixis, Inc. (NASDAQ: EXEL) presents an intriguing opportunity within the biotechnology landscape. With its focus on oncology, specifically in the development of..

Qiagen N.V. (QGEN) Stock Analysis: Exploring Growth Potential in the Diagnostics Sector

For investors keeping an eye on the healthcare sector, Qiagen N.V. (NYSE: QGEN) presents a compelling opportunity. As a key player in the diagnostics and research industry, Qiagen continues to..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds